Page last updated: 2024-12-06

miloxacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Miloxacin is a synthetic quinolone antibacterial agent that exhibits a broad spectrum of activity against gram-positive and gram-negative bacteria. It is known for its potent activity against Staphylococcus aureus, including methicillin-resistant strains. Its mechanism of action involves inhibiting bacterial DNA gyrase, an essential enzyme for DNA replication. Miloxacin is well absorbed after oral administration and reaches therapeutic concentrations in various tissues, including the lungs, skin, and urinary tract. Studies have explored its potential in treating infections like pneumonia, skin infections, and urinary tract infections. However, Miloxacin has been discontinued from commercial use due to concerns about its safety profile, including potential hepatotoxicity. Its discontinued use in the United States further limits its clinical application and research.'

miloxacin: structure in second source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37614
CHEMBL ID339309
CHEBI ID135084
SCHEMBL ID152466
MeSH IDM0081827

Synonyms (33)

Synonym
antibiotic ab 206
5,8-dihydro-5-methoxy-8-oxo-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid
ab 206
miloxacinum [inn-latin]
miloxacino [inn-spanish]
1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid, 5,8-dihydro-5-methoxy-8-oxo-
miloxacine [inn-french]
5,8-dihydro-5-methoxy-8-oxo-2h-1,3-dioxolo(4,5-g)quinoline-7-carboxylic acid
brn 0553059
5,8-dihydro-5-methoxy-8-oxo-1,3-dioxolo(4,5-g)chinolin-7-carbonsaeure
miloxacin [inn]
ab-206
miloxacin
37065-29-5
miloxacin (inn)
D02303
OPREA1_722351
CHEBI:135084
CHEMBL339309
5-methoxy-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
miloxacinum
unii-vm4w7043sn
miloxacino
miloxacine
vm4w7043sn ,
miloxacin-d3
miloxacin [mi]
SCHEMBL152466
DTXSID70190563
Q27291892
5,8-dihydro-5-methoxy-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; 1,4-dihydro-1-methoxy-6,7-(methylenedioxy)-4-quinolone-3-carboxylic acid; ab 206; antibiotic ab 206; fuldazin; miloxacin
5-methoxy-8-oxo-2h,5h,8h-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid
AKOS040748919

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Especially, all of the cases dosed with miloxacin over 34 mg/kg in a day showed excellent or good results."( [Chemotherapy on the biliary tract infections. XIII. Miloxacin, a novel chemotherapeutic agent, its excretion into bile and clinical effect on the biliary tract infections (author's transl)].
, 1981
)
0.78
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
quinolinesA class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (22)

Assay IDTitleYearJournalArticle
AID78688Inhibitory concentration in supercoiling inhibition Escherichia coli DNA gyrase assay1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID1137046Antibacterial activity against Klebsiella pneumoniae PCI-602 after 24 hrs by twofold dilution assay1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID164385Antibacterial activity against Pseudomonas aeruginosa (UI-18)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID1137051Drug level in Wistar rat serum at 50 mg/kg, po measured at 6 hrs1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137045Antibacterial activity against Pseudomonas aeruginosa 104 after 24 hrs by twofold dilution assay1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137052Antibacterial activity against Escherichia coli 0111 infected in ICR mouse administered orally 0.5 hr and 6 hrs post infection measured 1 week post challenge1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID95885Antibacterial activity against Klebsiella pneumonia (MGH-2)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID69782Antibacterial activity against Escherichia coli (H560)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID1137047Drug level in Wistar rat serum at 50 mg/kg, po measured at 0.5 hr1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137044Antibacterial activity against Proteus mirabilis GN 2425 after 24 hrs by twofold dilution assay1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137050Drug level in Wistar rat serum at 50 mg/kg, po measured at 4 hrs1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137053Antibacterial activity against Proteus mirabilis GN2425 infected in ICR mouse administered orally 0.5 hr and 6 hrs post infection measured 1 week post challenge1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137042Antibacterial activity against Staphylococcus aureus 209P after 24 hrs by twofold dilution assay1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137041Drug recovery in Wistar rat urine at 50 mg/kg, po measured over 24 hrs1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID78707MIC at which cleaved DNA (linear) is observed at an intensity relative to oxolinic acid at 10 ug/mL by using Gyrase Induced DNA-Cleavage assay1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID603953In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat2008European journal of medicinal chemistry, Mar, Volume: 43, Issue:3
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
AID210022Antibacterial activity against Streptococcus pneumoniae (SV-1)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID69784Antibacterial activity against Escherichia coli (vogel)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID1137048Drug level in Wistar rat serum at 50 mg/kg, po measured at 1 hr1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID1137049Drug level in Wistar rat serum at 50 mg/kg, po measured at 2 hrs1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
AID207175Antibacterial activity against Staphylococcus aureus (H228)1986Journal of medicinal chemistry, Mar, Volume: 29, Issue:3
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
AID1137043Antibacterial activity against Escherichia coli NIHJ after 24 hrs by twofold dilution assay1977Journal of medicinal chemistry, Jun, Volume: 20, Issue:6
Studies on quinoline derivatives and related compounds. 5. Synthesis and antimicrobial activity of novel 1-alkoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (81.25)18.7374
1990's1 (6.25)18.2507
2000's1 (6.25)29.6817
2010's1 (6.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.09 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies2 (12.50%)4.05%
Observational0 (0.00%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]